Breaks Categories: News

ThursdayJun 29, 2017 3:28 pm

CBDNewsBreaks – SinglePoint, Inc. (SING) Enters High-Volume Manufacturing Agreement with Premier Biomedical (BIEI)

Premier Biomedical, Inc. (OTCQB: BIEI), a research-based company focused on the discovery and development of medical treatments for a wide range of diseases, this morning announced that it has reached an agreement with specialized holding company SinglePoint, Inc. (OTC: SING) to manufacture Premier’s new-design CBD Hemp Oil Patch in high volume. “We have been working very hard on making acquisitions and inside sales to boost revenues,” Greg Lambrecht, CEO of SinglePoint, stated in the news release. “This new business will contribute significantly to our revenue goals.” Per the update, Premier’s CBD Hemp Oil Skin Patch is expected to be the…

Continue Reading

TuesdayJun 27, 2017 9:02 am

CBDNewsBreaks – SinglePoint, Inc. (SING) Subsidiary Receives Major Purchase Order from Premier Biomedical (BIEI)

Specialized holding company SinglePoint, Inc. (OTC: SING) this morning announced that its recently-acquired DIGS Hydro subsidiary has received a major purchase order from Premier Biomedical (OTCQB: BIEI). DIGS Hydro has already received the initial payment for this order, with final payment due upon delivery. “This opportunity for both SinglePoint and DIGS Hydro is fantastic,” Greg Lambrecht, CEO of SinglePoint, stated in the news release. “We have been working very hard on making acquisitions and inside sales to boost revenues. To have this subsidiary execute on its business plan and generate major revenue for SinglePoint is exactly what we want to…

Continue Reading

MondayJun 26, 2017 11:29 am

CBDNewsBreaks – 22nd Century Group, Inc. (NYSE: XXII) Added to Russell Microcap® Index

22nd Century Group (NYSE MKT: XXII) this morning announced its inclusion to the Russell Microcap® Index. The one-year membership to the index means the plant biotech company is automatically included in the appropriate growth and value style indexes. “We are pleased to be added to the Russell Microcap Index. Our inclusion will generate further interest in the Company’s stock among those investors in the investment community who may be less familiar with 22nd Century Group,” 22nd Century Group president and CEO Henry Sicignano, III, stated in the news release. Shares of 22nd Century Group are down 2.1% at $1.84, trading…

Continue Reading

MondayJun 26, 2017 9:48 am

CBDNewsBreaks – ABcann Global Corporation (TSXV: ABCN) Extends University of Guelph Research Agreement through 2018

ABcann Global Corporation (TSXV: ABCN) this morning announced that it has amended and extended the research contract currently in place between its Canadian operating subsidiary, ABcann Medicinals Inc., and the University of Guelph in Ontario, Canada. The agreement, which is focused on controlled environment production of medicinal cannabis, now extends to December 31, 2018, and offers an option to extend further if mutually agreed upon. “ABcann has pursued a unique approach to controlled environment production of cannabis designed to standardize the production and quality of medical compounds,” Dr. Michael Dixon, director of the Controlled Environment Systems Research Facility at the…

Continue Reading

WednesdayJun 21, 2017 3:00 pm

CBDNewsBreaks – Grow Condos, Inc. (GRWC) Provides Positive Update on ‘Smoke on the Water’ at Lake Selmac

Grow Condos (OTCQB: GRWC) this morning provided an update on "Smoke on the Water" at Lake Selmac, the company’s resort designed to cater to and capitalize on the country's persistently increasing level of recreational marijuana acceptance. The company reports that the park is undergoing a series of alterations, including culturally diverse upgrades and added value services for patrons of the resort. Among the highlights of the park’s changing atmosphere are the delivery of its tee-pees for its Native American section, which also features yoga and other spiritually enhancing activities. "Smoke on the Water" has launched its own roll up development…

Continue Reading

TuesdayJun 20, 2017 9:29 am

CBDNewsBreaks – SinglePoint, Inc. (SING) Secures Funding to Drive Development of Bitcoin Payment Solution

Specialized holding company SinglePoint, Inc. (OTC: SING) this morning announced that it has successfully closed a $1 million company-friendly convertible promissory note with an institutional investor. Per the update, the company intends to use this funding to execute on its previously announced bitcoin payments solution, which it is developing in partnership with First BitCoin Capital (OTC: BITCF). “This is great timing for SinglePoint. We have many acquisitions deals in the pipeline, and access to this capital will exponentially increase the chances of getting these done,” Greg Lambrecht, CEO of SinglePoint, stated in the news release. “In addition, we have many…

Continue Reading

ThursdayJun 15, 2017 3:52 pm

CBDNewsBreaks – MYM Nutraceuticals, Inc. (MYMMF) Appoints New Executive Chairman; Details Insider Share Purchases

MYM Nutraceuticals (CSE: MYM) (OTC: MYMMF) earlier this month appointed Erick Factor to the company’s board of directors and as executive chairman. As the founder of Vancouver-based “Westcoast Medicann” dispensary, Factor has 20 years of experience in cultivating medical marijuana and manufacturing cannabis by-products, and he has provided medical marijuana to thousands of patients over the past two decades. Additionally, the company released a list of company insiders who bought shares in the last private placement at $0.18; total proceeds from insider share purchases totaled $343,137.96. To view the full press release, visit: http://nnw.fm/e8PuU About MYM MYM Nutraceuticals Inc. (CSE:MYM)…

Continue Reading

ThursdayJun 15, 2017 8:51 am

CBDNewsBreaks – Player’s Network, Inc. (PNTV) Bolsters Leadership Team through Addition of Nevada Assistant Controller Geoffrey Lawrence as CFO, CCO

Player’s Network, Inc. (OTCQB: PNTV) this morning announced its appointment of Nevada Assistant Controller Geoffrey Lawrence as the company’s chief financial officer and chief compliance officer, effective July 1, 2017. “Geoffrey is a senior-level operator who will help us fulfill our commitment to our shareholders and the investment community insofar as our goals of increased transparency and stronger corporate governance,” Mark Bradley, CEO of PNTV, stated in the news release. “As PNTV continues to grow its assets, it is necessary that we assemble a strong first-class management team, and Geoffrey is a perfect fit, bringing to the table the necessary…

Continue Reading

WednesdayJun 14, 2017 9:25 am

CBDNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Targets Canadian Cannabis Market by Incorporating CBD Biotechnology Inc. in British Columbia

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced that it has incorporated CBD Biotechnology Inc. in British Columbia, Canada. “I am delighted about the incorporation of CBD Biotechnology Inc.,” Warren Wang, founder and CEO of CIIX, stated in the news release. “The incorporation of CBD Biotechnology Inc. is a promising step forward towards CIIX's goals to enter the medical marijuana industry. Through its expansion into Canada, CIIX aims generate significant revenues through sales of CBD-based health products, while helping the nearly one million Chinese in Canada to improve their overall health.” Canada promises to play a major role…

Continue Reading

TuesdayJun 13, 2017 9:00 am

CBDNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Teams with Pharmaseed to Advance Development of INM-750

Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced its entry into an agreement with Pharmaseed Ltd., Israel’s largest GLP-certified pre-clinical contract research organization. Under the terms of this agreement, the Pharmaseed development team will now play a key role in the ongoing development of InMed’s lead compound, INM-750, which is a proprietary, topical cannabinoid product candidate that’s currently being studied as a therapy in epidermolysis bullosa and other potential dermatological and wound-healing applications. “This agreement with Pharmaseed now adds one of Israel's leading formulation development teams to our efforts and represents an important strategic…

Continue Reading